Altered somatosensory processing in autism spectrum disorders: Mechanisms and emerging therapeutic opportunities
On April 24, 2019 David Ginty will present his work on the neurobiological basis of touch over-reactivity in mouse models of autism spectrum disorder (ASD), and discuss new pharmacological approaches aimed at reducing sensory over-reactivity and potentially improving cognitive and behavioral abnormalities associated with ASD.
On 1 February 2017, Arnold Kriegstein described recent advances in our understanding of the unique features of human cortical development and discussed insights into the origins of neurodevelopmental disorders.
On 25 January 2017, Jeremy Veenstra-VanderWeele outlined critical challenges to translating genomic, cellular, and animal model research into new treatments for autism spectrum disorder.
Associate Professor of Neurology, Harvard Medical School
On 2 November 2016, Beth Stevens discussed recent work that implicates brain immune cells, called microglia, in sculpting of synaptic connections during development and their relevance to autism, schizophrenia and other brain disorders.
Professor in Neurology, Harvard Medical School
On 5 October 2016, Mustafa Sahin presented an update on translational research in Tuberous Sclerosis Complex.
On 7 September 2016, Ruth O'Hara discussed the field’s current understanding of sleep in autism spectrum disorder.
Bullard Professor of Neurology, Harvard Medical School
On 27 April 2016, Christopher Walsh reviewed recent work on ‘somatic mutations’ — de novo mutations that are present in some brain cells but not in all cells of the body — in several neurological conditions associated with intellectual disability and seizures.